U.S. markets closed

Vericel Corporation (ATQP.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
25.94+0.59 (+2.33%)
At close: 08:02AM CET

Vericel Corporation

64 Sidney Street
Cambridge, MA 02139
United States
617 588 5555

Full Time Employees281

Key Executives

NameTitlePayExercisedYear Born
Mr. Dominick C. Colangelo Esq.CEO, Pres & Director1.36M1.68M1964
Mr. Joseph Anthony Mara Jr.CFO & Treasurer636.24kN/A1976
Mr. Michael HalpinChief Operating Officer672.86k2.2M1961
Mr. Sean C. FlynnSr. VP, Gen. Counsel & Sec.556.66k749.18k1974
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.Chief Medical Officer578.36k1.95M1962
Mr. Jonathan SiegalPrincipal Accounting Officer, VP & Corp. ControllerN/AN/AN/A
Mr. Eric BurnsExec. Director of Financial Planning and Analysis & Investor RelationsN/AN/AN/A
Mr. Patrick J. FowlerSr. VP of Corp. Devel. & StrategyN/AN/AN/A
Ms. Heidi HassenVP of HRN/AN/AN/A
Mr. Roland DeAngelisSr. VP of Commercial OperationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Vericel Corporation’s ISS Governance QualityScore as of January 28, 2023 is 4. The pillar scores are Audit: 5; Board: 3; Shareholder Rights: 4; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.